According to research report the global competent cells market is projected to reach USD 2.22 billion by 2022 from USD 1.37 billion in 2017, at a CAGR of 10.2%.
Download PDF Brochure: https://www.marketsandmarkets.com/requestsampleNew.asp?id=265815900
Advancements in molecular cloning research due to the emergence of new technologies and increasing commercial demand for molecular cloned products and recombinant proteins are the major factors driving the growth of the competent cells market.
North America to dominate the competent cells market in 2017
By region, the global competent cells market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2017, North America is expected to account for the largest share of the market. This can be attributed to the increasing intensity of research due to technological advancement and increasing commercial needs for genomic and protein expressed products, in North American countries.
By application, the cloning segment is expected to dominate the market in 2017
Based on application, the competent cells market is broadly segmented into cloning, protein expression, and other applications. Cloning is expected to command the largest share of this market in 2017. Increasing research on cloning, driven by government support and funding is among the major factors driving market growth in this segment.
The cloning application is further segmented into subcloning & routine cloning, phage display library construction, toxic/unstable DNA cloning, and high-throughput cloning. Similarly, other applications of competent cells include mutagenesis, single-stranded DNA production, lentiviral vector production, and large plasmid transformation.
By type, the chemically competent cells segment is expected to dominate the market in 2017
Based on the type of competent cells, the market is segmented into chemically competent cells and electrocompetent cells. The growth of the chemically competent cells segment can be attributed to the rising intensity of research (due to technological advancement) and availability of government support, along with the growing market demand for molecular cloned products.
By end user, the academic research institutes segment is expected to dominate the market in 2017
On the basis of end user, the competent cells market is segmented into academic research institutes, contract research organizations (CROs), and pharmaceutical & biotechnology companies. In 2017, the academic research institutes segment is expected to account for the largest share of the market. The growth of this end-user segment is driven by the increase in research funding for life science projects worldwide.
Key players operating in the competent cells market include Merck KGaA (Germany), Promega Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S), New England Biolabs (U.S.), Takara Bio (Japan), Agilent Technologies (U.S.), Lucigen (Epicenter) (Illumina) (U.S.), QIAGEN N.V. (Germany), OriGene Technologies (U.S.), Bioline (U.K.), Zymo Research (U.S.), Beijing TransGen Biotech Co., Ltd. (China), Source BioScience (U.K.), IBA GmBH (Germany), Genewiz (U.S.), BioDynamics Laboratory, Inc. (Japan), GCC Biotech (India), SMOBIO Technology (Taiwan), GeneScript Corporation (U.S.), Bio-Rad Laboratories (U.S.), Life Technologies (India) Pvt. Ltd., Cell Applications, Inc. (U.S.), Delphi Genetics (Belgium), Scarab Genomics, LLC (U.S.), and Yeastern Biotech Co., Ltd. (Taiwan).
Get the Sample Pages: http://www.marketsandmarkets.com/requestsample.asp?id=265815900
Competent Cells Market Size, Share, Trends and industry analysis
The growth of Protein Expression Market is driven majorly by the increasing incidence of chronic diseases, growth in the geriatric population, and increasing demand for protein biologics.
Emerging economies are likely to create significant growth opportunities for players in the market.
However, the high cost of protein expression reagents and instruments, along with increasing consolidation and high barriers for new entrants, will challenge market growth.According to the new market research report “Protein Expression Market by Type (Escherichia Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus and Cell-free), Products (Reagents, Competent Cells, Instruments, Services), Application, End-User and Region – Global Forecast to 2025” published by MarketsandMarkets™, is projected to reach USD 4.1 billion by 2025 from USD 2.2 billion in 2020, at a CAGR of 13.2% between 2020 and 2025.Recent Developments:In 2020, Thermo Fisher Scientific Inc. acquired the biotechnology company, Qiagen (Germany).
This acquisition will help Thermo Fisher Scientific to enhance its precision medicine portfolio through molecular diagnostics and improved life sciences solutions.In 2020, Merck announced plans for the construction of a new biotech development facility in Switzerland.
This acquisition expanded Agilent’s presence and expertise in cell analysis and strengthened its position in the growing immune-oncology and immunotherapy areas.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=180323924Geographically; North America dominated the protein expression sector, followed by Europe.
The major factors driving the growth of this market include the increasing incidence of chronic diseases, growth in the geriatric population, and increasing demand for protein biologics.The prominent players in protein expression market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Genscript Biotech Corporation (US), Takara Bio, Inc. (Japan), Bio-Rad Laboratories (US), Lonza (US), Promega Corporation (US), New England Biolabs (US), Oxford Expression Technologies Ltd. (US), and Synthetic Genomics Inc. (US).Thermo Fisher Scientific Inc. is the largest player in the market.
Protein Expression Market Protein expression is the technique of measuring the activity of thousand genes at once.
It consists of some biotechnological technique, which covert the DNA information into RNA regulation.
Scientists are now a days making specific predictions about protein expression.
Protein modification and synthesis is known as protein expression.
It is widely used in treatment of genetic diseases.
Increasing incidence of chronic disease is enhancing the market growth.Market DriversOpportunities in the field of proteomics are driving the market growthEscalation in the biologics market will boost the market growthIncreasing incidence of chronic diseases will flourish the market growthSupport from the governments is driving the market growth, in handling the regulations and fundingMarket RestraintsDecreased investments hindering the growth of the marketIncreasing consolidation and high barriers for new entrants act as a restraint for the market growthGet Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-protein-expression-marketSome of the leading key players profiled in this study:Some of the major players operating in global protein expression market are Thermo Fisher Scientific Inc., Merck KGaA, Promega Corporation, Agilent Technologies, Domainex, Biomatik, Syngene, Accelagen Inc., R Systems, Inc., Enzo Life Sciences, Inc., Abnova Corporation, OriGene Technologies GenScript, TAKARA HOLDINGS INC., Bio-Rad Laboratories, Inc., Qiagen N.V., LONZA, New England Biolabs Inc., Sengenics, ProteoGenix, Synthetic Genomics Inc., Lucigen, Oxford Expression Technologies Ltd., Novoprotein, Biocompare, exonbio, and Sino Biological Inc. among others Browse Related Report Here:Electrosurgery Equipment Market Electrosurgery Equipment Market Key Pointers Covered in the Protein Expression Market Trends and Forecast to 2026Protein Expression Market New Sales VolumesProtein Expression Market Replacement Sales VolumesProtein Expression Market Installed BaseProtein Expression Market By BrandsProtein Expression Market SizeProtein Expression Market Procedure VolumesProtein Expression Market Product Price AnalysisProtein Expression Market Healthcare OutcomesProtein Expression Market Cost of Care AnalysisProtein Expression Market Regulatory Framework and ChangesProtein Expression Market Prices and Reimbursement AnalysisProtein Expression Market Shares in Different RegionsRecent Developments for Protein Expression Market CompetitorsProtein Expression Market Upcoming ApplicationsProtein Expression Market Innovators Study Get Detailed Toc and Charts & Tables @ https://www.databridgemarketresearch.com/toc/?dbmr=global-protein-expression-marketScope of the Protein Expression MarketCurrent and future of Protein Expression Market outlook in the developed and emerging marketsThe segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast periodRegions/Countries that are expected to witness the fastest growth rates during the forecast periodThe latest developments, market shares, and strategies that are employed by the major market playersGlobal Protein Expression Market By Organ System Type (Prokaryotic Expression, Mammalian Cell Expression, Insect Cell Expression, Yeast Expression, Cell-Free Expression, Algal-Based Expression), Product & Service (Reagents, Expression Vectors, Competent Cells, Instruments, Services), By Application(Therapeutic, Industrial, Research), End User( Pharmaceutical and Biotech Companies, Academic Research, Contract Research Organization, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East And Africa) - Industry Trends and Forecast To 2026 – Industry Trends and Forecast to 2026 Inquiry before Buying @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-protein-expression-marketAbout Us: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.
The Global Recombinant Expression Systems Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.An expression system is a system specifically designed for the production of a gene product of choice.
This is normally a protein although may also be RNA, such as tRNA or a ribozyme.
An expression system consists of a gene, normally encoded by DNA, and the molecular machinery required to transcribe the DNA into mRNA and translate the mRNA into protein using the reagents provided.
Expression systems are classified on the basis of functionality, solubility, yield, level of target gene expression, and post translational processing.The recombinant expression systems market is expected to grow owing to increased research in pharmaceutical sector and growth in biologics market.
The overall growth in proteomics market is also a major factor driving this market.
The Global Recombinant Expression Systems Market Report, with its deep industry analysis of the market, estimates the market size bifurcated into segments and regions.
The Recombinant Expression Systems market share and growth, trends estimated at the end of 2027 give a fair idea of the new opportunities coming up in the market.
The detailed key player's profile and market share analysis give a better understanding of the competitors and their business strategies.Base Year: 2020Estimated Year: 2021Forecast Till: 2027The report classifies the market into different segments based on type and product.
These segments are studied in detail, incorporating the market estimates and forecasts at regional and country levels.
The segment analysis is helpful in understanding the growth areas and potential opportunities of the market.Get | Download FREE Sample Report of Global Recombinant Expression Systems Market @ https://www.decisiondatabases.com/contact/download-sample-418A special section is dedicated to the analysis of the impact of the COVID-19 pandemic on the growth of the Recombinant Expression Systems market.
The impact is closely studied in terms of production, import, export, and supply.The report covers the complete competitive landscape of the Worldwide Recombinant Expression Systems market with company profiles of key players such as:Agilent Technologies, IncBio-Rad Laboratories, Inc.Life Technologies CorporationMerck MilliporeNew England Biolabs, Inc.Promega CorporationQiagenSigma-Aldrich CorporationTakara Bio, Inc.Thermo Fischer Scientific Inc.Want to add more Company Profiles to the Report?
Protein Expression Market Protein expression is the technique of measuring the activity of thousand genes at once.
It consists of some biotechnological technique, which covert the DNA information into RNA regulation.
Scientists are now a days making specific predictions about protein expression.
Protein modification and synthesis is known as protein expression.
It is widely used in treatment of genetic diseases.
Increasing incidence of chronic disease is enhancing the market growth.Market DriversOpportunities in the field of proteomics are driving the market growthEscalation in the biologics market will boost the market growthIncreasing incidence of chronic diseases will flourish the market growthSupport from the governments is driving the market growth, in handling the regulations and fundingMarket RestraintsDecreased investments hindering the growth of the marketIncreasing consolidation and high barriers for new entrants act as a restraint for the market growthGet Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-protein-expression-marketSome of the leading key players profiled in this study:Some of the major players operating in global protein expression market are Thermo Fisher Scientific Inc., Merck KGaA, Promega Corporation, Agilent Technologies, Domainex, Biomatik, Syngene, Accelagen Inc., R Systems, Inc., Enzo Life Sciences, Inc., Abnova Corporation, OriGene Technologies GenScript, TAKARA HOLDINGS INC., Bio-Rad Laboratories, Inc., Qiagen N.V., LONZA, New England Biolabs Inc., Sengenics, ProteoGenix, Synthetic Genomics Inc., Lucigen, Oxford Expression Technologies Ltd., Novoprotein, Biocompare, exonbio, and Sino Biological Inc. among others Browse Related Report Here:Electrosurgery Equipment Market Electrosurgery Equipment Market Key Pointers Covered in the Protein Expression Market Trends and Forecast to 2026Protein Expression Market New Sales VolumesProtein Expression Market Replacement Sales VolumesProtein Expression Market Installed BaseProtein Expression Market By BrandsProtein Expression Market SizeProtein Expression Market Procedure VolumesProtein Expression Market Product Price AnalysisProtein Expression Market Healthcare OutcomesProtein Expression Market Cost of Care AnalysisProtein Expression Market Regulatory Framework and ChangesProtein Expression Market Prices and Reimbursement AnalysisProtein Expression Market Shares in Different RegionsRecent Developments for Protein Expression Market CompetitorsProtein Expression Market Upcoming ApplicationsProtein Expression Market Innovators Study Get Detailed Toc and Charts & Tables @ https://www.databridgemarketresearch.com/toc/?dbmr=global-protein-expression-marketScope of the Protein Expression MarketCurrent and future of Protein Expression Market outlook in the developed and emerging marketsThe segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast periodRegions/Countries that are expected to witness the fastest growth rates during the forecast periodThe latest developments, market shares, and strategies that are employed by the major market playersGlobal Protein Expression Market By Organ System Type (Prokaryotic Expression, Mammalian Cell Expression, Insect Cell Expression, Yeast Expression, Cell-Free Expression, Algal-Based Expression), Product & Service (Reagents, Expression Vectors, Competent Cells, Instruments, Services), By Application(Therapeutic, Industrial, Research), End User( Pharmaceutical and Biotech Companies, Academic Research, Contract Research Organization, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East And Africa) - Industry Trends and Forecast To 2026 – Industry Trends and Forecast to 2026 Inquiry before Buying @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-protein-expression-marketAbout Us: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.
The growth of Protein Expression Market is driven majorly by the increasing incidence of chronic diseases, growth in the geriatric population, and increasing demand for protein biologics.
Emerging economies are likely to create significant growth opportunities for players in the market.
However, the high cost of protein expression reagents and instruments, along with increasing consolidation and high barriers for new entrants, will challenge market growth.According to the new market research report “Protein Expression Market by Type (Escherichia Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus and Cell-free), Products (Reagents, Competent Cells, Instruments, Services), Application, End-User and Region – Global Forecast to 2025” published by MarketsandMarkets™, is projected to reach USD 4.1 billion by 2025 from USD 2.2 billion in 2020, at a CAGR of 13.2% between 2020 and 2025.Recent Developments:In 2020, Thermo Fisher Scientific Inc. acquired the biotechnology company, Qiagen (Germany).
This acquisition will help Thermo Fisher Scientific to enhance its precision medicine portfolio through molecular diagnostics and improved life sciences solutions.In 2020, Merck announced plans for the construction of a new biotech development facility in Switzerland.
This acquisition expanded Agilent’s presence and expertise in cell analysis and strengthened its position in the growing immune-oncology and immunotherapy areas.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=180323924Geographically; North America dominated the protein expression sector, followed by Europe.
The major factors driving the growth of this market include the increasing incidence of chronic diseases, growth in the geriatric population, and increasing demand for protein biologics.The prominent players in protein expression market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Genscript Biotech Corporation (US), Takara Bio, Inc. (Japan), Bio-Rad Laboratories (US), Lonza (US), Promega Corporation (US), New England Biolabs (US), Oxford Expression Technologies Ltd. (US), and Synthetic Genomics Inc. (US).Thermo Fisher Scientific Inc. is the largest player in the market.
The Global Recombinant Expression Systems Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.An expression system is a system specifically designed for the production of a gene product of choice.
This is normally a protein although may also be RNA, such as tRNA or a ribozyme.
An expression system consists of a gene, normally encoded by DNA, and the molecular machinery required to transcribe the DNA into mRNA and translate the mRNA into protein using the reagents provided.
Expression systems are classified on the basis of functionality, solubility, yield, level of target gene expression, and post translational processing.The recombinant expression systems market is expected to grow owing to increased research in pharmaceutical sector and growth in biologics market.
The overall growth in proteomics market is also a major factor driving this market.
The Global Recombinant Expression Systems Market Report, with its deep industry analysis of the market, estimates the market size bifurcated into segments and regions.
The Recombinant Expression Systems market share and growth, trends estimated at the end of 2027 give a fair idea of the new opportunities coming up in the market.
The detailed key player's profile and market share analysis give a better understanding of the competitors and their business strategies.Base Year: 2020Estimated Year: 2021Forecast Till: 2027The report classifies the market into different segments based on type and product.
These segments are studied in detail, incorporating the market estimates and forecasts at regional and country levels.
The segment analysis is helpful in understanding the growth areas and potential opportunities of the market.Get | Download FREE Sample Report of Global Recombinant Expression Systems Market @ https://www.decisiondatabases.com/contact/download-sample-418A special section is dedicated to the analysis of the impact of the COVID-19 pandemic on the growth of the Recombinant Expression Systems market.
The impact is closely studied in terms of production, import, export, and supply.The report covers the complete competitive landscape of the Worldwide Recombinant Expression Systems market with company profiles of key players such as:Agilent Technologies, IncBio-Rad Laboratories, Inc.Life Technologies CorporationMerck MilliporeNew England Biolabs, Inc.Promega CorporationQiagenSigma-Aldrich CorporationTakara Bio, Inc.Thermo Fischer Scientific Inc.Want to add more Company Profiles to the Report?